Blog Category: On-Demand

Individualizing Guideline Concordant Care: T2D and Patients with Multimorbid Conditions

GLP-1 receptor agonists (GLP-1 RAs) are a top-tier recommendation for patients with type 2 diabetes (T2D), especially those with concomitant cardiovascular disease (CVD), chronic kidney disease (CKD), or obesity. Backed by robust clinical trial data and endorsed across leading guidelines, …

Preventing the Preventable: Safe Mycophenolate Practices in Patients of Childbearing Potential

Mycophenolate-containing medications are widely used to prevent organ rejection in transplant recipients and to treat (off label) some autoimmune conditions such as lupus; however, use of these immunosuppressive agents during pregnancy is linked to a significantly increased risk of miscarriage …

GLP-1 RA Myths & Realities: Navigating Safety and Tolerability

GLP-1 receptor agonists (GLP-1 RAs) have redefined the standard of care for type 2 diabetes (T2D), especially in patients with cardiovascular disease (CVD), chronic kidney disease (CKD), obesity, or metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis (MASLD/MASH). These innovative therapies …

Nursing Knowledge, Social Impact: Meeting the Needs of Underserved Patients

Underserved patient populations often face significant health disparities rooted in unaddressed social drivers of health (SDOH), such as food insecurity, housing instability, and limited access to care. These social needs directly contribute to poor health outcomes and preventable health complications. …

The Nursing Network: Bias, Barriers, and Breakthroughs in Care

There is a critical and ongoing need to educate nurses and nurse practitioners, who often form the backbone of patient care delivery, about the presence and impact of unconscious bias in clinical settings. As essential connectors within the healthcare provider …